HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nutritional status in relation to the efficacy of the rhesus-human reassortant, tetravalent rotavirus vaccine (RRV-TV) in infants from Belém, pará state, Brazil.

Abstract
The rhesus-human reassortant, tetravalent rotavirus vaccine (RRV-TV) was licensed for routine use in the United States of America but it was recently withdrawn from the market because of its possible association with intussusception as an adverse event. The protective efficacy of 3 doses of RRV-TV, in its lower-titer (4 x 10(4) pfu/dose) formulation, was evaluated according to the nutritional status of infants who participated in a phase III trial in Belém, Northern Brazil. A moderate protection conferred by RRV-TV was related to weight-for-age Z-scores (WAZ) greater than -1 only, with rates of 38% (p = 0.04) and 40% (p = 0.04) for all- and- pure rotavirus diarrhoeal cases, respectively. In addition, there was a trend for greater efficacy (43%, p = 0.05) among infants reaching an height-for-age Z-score (HAZ) of > -1. Taking WAZ, HAZ and weight-for-height Z-score (WHZ) indices </= -1 together, there was no significant protection (p > 0.05) if both placebo and vaccine groups are compared. There was no significant difference if rates of mixed and pure rotavirus diarrhoeal cases are compared in relation to HAZ, WAZ and weight-for-height Z-score (WHZ) indices. Although a low number of malnourished infants could be identified in the present study, our data show some evidence that malnutrition may interfere with the efficacy of rotavirus vaccines in developing countries.
AuthorsAlexandre C Linhares, Kênea B do Carmo, Krynssya K Oliveira, Consuelo S Oliveira, Ronaldo B de Freitas, Newton Bellesi, Talita A F Monteiro, Yvone B Gabbay, Joana D'Arc P Mascarenhas
JournalRevista do Instituto de Medicina Tropical de Sao Paulo (Rev Inst Med Trop Sao Paulo) 2002 Jan-Feb Vol. 44 Issue 1 Pg. 13-6 ISSN: 0036-4665 [Print] Brazil
PMID11896407 (Publication Type: Clinical Trial, Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial)
Chemical References
  • Rotavirus Vaccines
  • Vaccines, Attenuated
  • rhesus rotavirus vaccine
Topics
  • Animals
  • Anthropometry
  • Brazil
  • Developed Countries
  • Diarrhea (prevention & control, virology)
  • Double-Blind Method
  • Gastroenteritis (prevention & control, virology)
  • Humans
  • Infant
  • Infant, Newborn
  • Nutritional Status
  • Reassortant Viruses (immunology)
  • Rotavirus (immunology)
  • Rotavirus Infections (prevention & control)
  • Rotavirus Vaccines (therapeutic use)
  • Vaccines, Attenuated (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: